Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of...
Patent
1995-06-06
1998-06-23
Chambers, Jasemine C.
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
4353201, 435 691, 4351723, 435 912, 536 231, 536 235, 536 2431, 935 23, 935 78, 935 79, 935 70, 935 71, C12N 1509, C12N 1563
Patent
active
057704430
ABSTRACT:
The present invention provides a novel family of apoptosis-modulating proteins. Nucleotide and amino acid residue sequences and methods of use thereof are also provided.
REFERENCES:
patent: 5656725 (1997-08-01), Chittenden et al.
patent: 5672686 (1997-09-01), Chittenden
Orkin et al., Report and Recommendations of the Panel to Assess the NIH Investment in Research on Gene Therapy, Dec. 7, 1995.
Coghlan, Focus, vol. 148, pp. 14-15, Nov. 25, 1995.
Brown, "News Media, Researchers `Oversold` Gene Therapy, Advisory Panel Says", The Washington Post, Dec. 8, 1995.
Marshall, Science, vol. 269, pp. 1050-1055, Aug. 25, 1995
Kanter et al., "Epidermal growth factor and tumor promoters prevent DNA fragmentation by different mechanisms" Biochem. Biophys. Res. Commun. (1984) 118:392-399.
Duke et al., "IL-2 addiction: Withdrawal of growth factor activates a suicide program in dependent T cells" Lymphokine Res. (1986) 5:289-299.
Tomei et al., "Inhibition of radiation-induced apoptosis in vitro by tumor promoters" Biochem. Biophys. Res. Commun. (1988) 155:324-331.
Kruman et al., "Apoptosis of murine BW 5147 thymoma cells induced by dexamethasone and .gamma.-irradiation" J. Cell. Physiol. (1991) 148:267-273.
Ameisen et al., "Cell dysfunction and depletion in AIDS: The programmed cell death hypothesis" Immunol. Today (1991) 12:102-105.
Sheppard et al., "The relationship between AIDS and immunologic intolerance" J. AIDS (1992) 5:143-147.
Gerschenson et al., "Apoptosis: A different type of cell death" FASEB J. (1992) 6:2450-2455.
Cohen et al., "Apoptosis and programmed cell death in immunity" Ann. Rev. Immunol. (1992) 10:267-293.
Tsujimoto et al., "Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation" Science (1984) 226:1097-1099.
Cleary et al., "Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobin transcript resulting from the t(14;18) translocation" Cell (1986) 47:19-28.
McDonnell et al., "Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18)" Nature (1991) 349:254-256.
Edgington, "Looking death in the eye: Apoptosis and cancer research" Biotechnol. (1993) 11:787-792.
Sentman et al., "bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes" Cell (1991) 67:879-888.
Strasser, "bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship" Cell (1991) 67:889-899.
Hockenbery et al., "Bcl-2 functions in an antioxidant pathway to prevent apoptosis" Cell (1993) 75:241-251.
Williams et al., "Molecular regulation of apoptosis: genetic controls on cell death" Cell (1993) 74:777-779.
Zhu et al., "Systemic gene expression after intravenous DNA delivery into adult mice" Science (1993) 261:209-211.
Veis et al., "Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair" Cell (1993) 75:229-240.
Kiefer et al., "Molecular cloning of a new human insulin-like growth factor binding protein" Biochem. Biophys. Res. Commun. (1991) 176:219-225.
Sanger et al., "DNA sequencing with chain-terminating inhibitors" Proc. Natl. Acad. Sci. USA (1977) 74:5463-5467.
Boise et al., "bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death" Cell (1993) 74:597-608.
Oltvai et al., "Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death" Cell (1993) 74:609-619.
Zapf et al., "Isolation from adult human serum of four insulin-like growth factor (IGF) binding proteins and molecular cloning of one of them that is increased by IGF I administration and in extrapancreatic tumor hypoglycemia" J. Biol. Chem. (1990). 265:14892-14898.
Feinberg et al., "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity" Anal. Biochem. (1984) 137:266-267.
Chen-Levy et al., "The bcl-2 candidate proto-oncogene product is a 24-kilodalton integral-membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t(14;18) translocation" Mol. Cell. Biol. (1989) 9:701-710.
Jacobson et al., "Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA" Nature (1993) 361:365-369.
Monaghan et al., "Ultrastructural localization of BCL-2 protein" J. Histochem. Cytochem. (1992) 40:1819-1825.
Lehrach et al., "RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical reexamination" Biochem. (1977) 16:4743-4751.
Thomas, "Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose" Proc. Natl. Acad. Sci. USA (1980) 77:5201-5205.
Barr, "Expression of foreign genes in yeast" Transgenesis (1992) Murray, J.A.H., ed., Wiley & Sons, New York, pp. 55-79.
Henderson et al., "Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death" Proc. Natl. Acad. Sci. USA (1993) 90:8479-8483.
Viegas-Pequignot, "In situ hybridization to chromosomes with biotinylated probes" In Situ Hybridization. A Practical Approach, D.G. Wilkinson, ed., IRL Press, Oxford, pp. 137-158.
Pinkel et al., "Fluorescence in situ hybrization with human chromosome-specific libraries: Detection of trisomy 21 and translocations of chromosome 4" Proc. Natl. Acad. Sci. USA (1988) 85:9138-9142.
McKearn et al., "Enrichment of hematopoietic precursor cells and cloning of multipotential B-lymphocyte precursors" Proc. Natl. Acad. Sci. USA (1985) 82:7414-7418.
Nunez et al., "Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines" J. Immunol, (1990) 144:3602-3610.
Hockenbery et al., "Bcl-2 is an inner mitochondrial protein that blocks programmed cell death" Nature (1990) 34:334-336.
Cherif et al., "Ordering markers in the region of the ataxia-telangiectasia gene (11q22-q23) by fluorescence in situ hybridization (FISH) to interphase nuclei" Hum. Genet, (1994) 93:1-6.
Foroud et al., "Localization of an ataxia-telangiectasia locus to a 3-cM interval on chromosome 11q23: Linkage analysis of 111 families by an international consortium" Am. J. Hum. Genet. (1991) 49:1263-1279.
Kapp et al., "Cloning of a candidate gene for ataxia-telangiectasia group D" Am. J. Hum. Genet, (1992) 51:45-54.
Khati et al., "Genetic heterogeneity of autosomal dominant cerebellar ataxia type 1: Clinical and genetic analysis of 10 French families" Neurology (1993) 43:1131-1137.
Meyn, "Ataxia-telangiectasia, apoptosis and cellular responses to DNA damage: A model" Cancer Genet. (1993) 53:(Abstract No. 1529).
Orr et al., "Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1" Nature Genetics (1993) 4:221-226.
Kennedy, "Prevention of carcinogenesis by protease inhibitors" Cancer Res. (1994) 54:1999s-2005s.
Lam et al., "Evidence that BCL-2 represses apoptosis by regulating endoplasmic reticulum-associated Ca.sup.2+ fluxes" Proc. Natl. Acad. Sci. USA (1994) 91:6569-6573.
Reed et al., "Antisense-mediated inhibition of BCL2 protooncogene expression and leukemic cell growth and survival: Comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides" Cancer Res. (1990) 50:6565-6570.
Yonehara et al., "A cell-killing monoclonal antibody (ANTI-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor" J. Exp. Med. (1989) 169:1747-1756.
Hickish et al., "Ultrastructural localization of BHRF1: An Epstein-Barr virus gene product which has homology with bcl-2" Cancer Research (1994) 54:2808-2811.
Tarodi et al., "Epstein-Barr virus BHRF1 protein protects against cell death induced by DNA-damaging agents and heterologous viral infection" Virology (1994) 201:404-407.
Chittenden et al., "Induction of apoptosis by the Bcl-2 homologue Bak" Nature (1995) 347:733-736.
Farrow et al., "Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K" Nature (1995) 374:731-733.
Kiefer et al., "Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak" Nature (1995) 374:736-739.
Wyllie, "Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation
Barr Philip J.
Kiefer Michael C.
Chambers Jasemine C.
LXR Biotechnology Inc.
Schmuck Jill D.
LandOfFree
Apoptosis-modulating proteins, DNA encoding the proteins and met does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Apoptosis-modulating proteins, DNA encoding the proteins and met, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Apoptosis-modulating proteins, DNA encoding the proteins and met will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1393734